BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ferrarese A, Germani G, Gambato M, Russo FP, Senzolo M, Zanetto A, Shalaby S, Cillo U, Zanus G, Angeli P, Burra P. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study. World J Gastroenterol 2018; 24(38): 4403-4411 [PMID: 30344424 DOI: 10.3748/wjg.v24.i38.4403]
URL: https://www.wjgnet.com/1007-9327/full/v24/i38/4403.htm
Number Citing Articles
1
Francesco Negro. Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV TherapyCold Spring Harbor Perspectives in Medicine 2020; 10(4): a036921 doi: 10.1101/cshperspect.a036921
2
Edna STRAUSS. CHRONIC HEPATITIS C IS STILL A PROBLEM FOR THE PUBLIC HEALTH CARE SYSTEM IN BRAZILArquivos de Gastroenterologia 2018; 55(4): 321 doi: 10.1590/s0004-2803.201800000-90
3
William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun S. Kim. Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular CarcinomaScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53051-2
4
Wei-Chen Lin, Yang-Sheng Lin, Chen-Wang Chang, Ching-Wei Chang, Tsang-En Wang, Horng-Yuan Wang, Ming-Jen Chen, Chen-Hua Liu. Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinomaPLOS ONE 2020; 15(5): e0233212 doi: 10.1371/journal.pone.0233212
5
Patrizia Burra, Debora Bizzaro, Anna Gonta, Sarah Shalaby, Martina Gambato, Maria Cristina Morelli, Silvia Trapani, Annarosa Floreani, Fabio Marra, Maurizia Rossana Brunetto, Gloria Taliani, Erica Villa. Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH)Liver International 2021; 41(8): 1713 doi: 10.1111/liv.14943
6
William M. Kamp, Cortlandt M. Sellers, Stacey Stein, Joseph K. Lim, Hyun S. Kim. Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology 2020; 31(6): 953 doi: 10.1016/j.jvir.2019.12.809
7
Renata Senkerikova, Sona Frankova, Milan Jirsa, Miluse Kreidlova, Dusan Merta, Magdalena Neroldova, Klara Chmelova, Julius Spicak, Jan Sperl, Pavel Strnad. PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger agePLOS ONE 2019; 14(9): e0222609 doi: 10.1371/journal.pone.0222609
8
Vijay Gayam, Arshpal Gill, Pavani Garlapati, Smruti Mohanty. Hepatitis B and C2020;  doi: 10.5772/intechopen.83609
9
Francesco Paolo Russo, Alberto Zanetto, Elisa Pinto, Sara Battistella, Barbara Penzo, Patrizia Burra, Fabio Farinati. Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?International Journal of Molecular Sciences 2022; 23(1): 500 doi: 10.3390/ijms23010500
10
Elena Campello, Claudia M. Radu, Alberto Zanetto, Cristiana Bulato, Sarah Shalaby, Luca Spiezia, Enrica Franceschet, Patrizia Burra, Francesco P. Russo, Paolo Simioni. Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antiviralsLiver International 2020; 40(4): 913 doi: 10.1111/liv.14234
11
Hugo Perazzo, Rodolfo Castro, Paula M Luz, Mariana Banholi, Rafaela V Goldenzon, Sandra W Cardoso, Beatriz Grinsztejn, Valdilea G Veloso. Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysisBulletin of the World Health Organization 2020; 98(3): 188 doi: 10.2471/BLT.19.231522
12
Giuseppe Losurdo, Andrea Iannone, Antonella Contaldo, Michele Barone, Enzo Ierardi, Alfredo Di Leo, Mariabeatrice Principi. Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis CDiagnostics 2020; 10(12): 1037 doi: 10.3390/diagnostics10121037
13
Ying Yang, Feng-Ping Wu, Wen-Jun Wang, Juan-Juan Shi, Ya-Ping Li, Xin Zhang, Shuang-Suo Dang. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest ChinaWorld Journal of Gastroenterology 2019; 25(44): 6551-6560 doi: 10.3748/wjg.v25.i44.6551
14
Elio C. Castro Filho, Juliana Piedade, Rodolfo Castro, Paula M. Luz, Flavia Fernandes, Beatriz Grinsztejn, Valdilea G. Veloso, Gustavo Henrique Pereira, Hugo Perazzo. Effectiveness of direct‐acting agents for chronic hepatitis C treatment in South America: A systematic review and meta‐analysisJournal of Viral Hepatitis 2020; 27(12): 1396 doi: 10.1111/jvh.13364
15
Giuseppina Brancaccio, Alessandro Vitale, Giuseppe Signoriello, Giovanni B. Gaeta, Umberto Cillo. Changing indications for liver transplant: slow decline of hepatitis viruses in ItalyInfectious Diseases 2020; 52(8): 557 doi: 10.1080/23744235.2020.1763453
16
Stella Compagnoni, Erica Maria Bruno, Giorgio Madonia, Marco Cannizzaro, Salvatore Madonia. Direct antiviral agents in hepatitis C virus related liver disease: Don’t count the chickens before they’re hatchedWorld Journal of Gastroenterology 2021; 27(21): 2771-2783 doi: 10.3748/wjg.v27.i21.2771